MedPath

A study on the cost-effectiveness of risk scoring models for the discrimination between benign or malignant ovarian tumors

Not Applicable
Recruiting
Conditions
<p>Ovarian tumors</p>
10038594
Registration Number
NL-OMON23155
Lead Sponsor
The Netherlands Organisation for Health Research and Development (ZonMW)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
584
Inclusion Criteria

|
1. Leeftijd = 18 jaar |

Exclusion Criteria

|
1. Een duidelijk goedaardige ovariumtumor: |

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Quality of Life (measured by the EuroQol-5D (EQ-5D)</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Physical and mental health status (Short Form 12), Healthcare resource use costs (iMCQ instrument), Productivity losses (iPCQ instrument), Extend of cancer worries and anxiety (Cancer Worry Scale (CWS), Hospital Anxiety And Depression Scale (HADS), Intolerance of Uncertainty Scale (IUS 12) .</p><br>
© Copyright 2025. All Rights Reserved by MedPath